We are live on
!
Find out more
Nicholas Hoffman & Company Portfolio holdings
AUM
$4.74B
Turnover
9.12%
1-Year Est. Return
18.12%
This Fund
S&P 500
This Quarter
Est. Return
+6.31%
1 Year Est. Return
+18.12%
3 Year Est. Return
+65.12%
5 Year Est. Return
+53.27%
10 Year Est. Return
+210.2%
AUM
$255M
AUM Growth
+$17.4M
(+7.3%)
Cap. Flow
+$3.23M
Cap. Flow
% of AUM
1.27%
Top 10 Holdings %
Top 10 Hldgs %
40.98%
Holding
173
New
9
Increased
70
Reduced
65
Closed
7
Avg Time Held
1.2
years
Top 10 Avg Time Held
1.2
years
Top 20 Avg Time Held
1.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$2.37M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$874K |
| 3 |
SLB Ltd
SLB
|
+$547K |
| 4 |
Vanguard Dividend Appreciation ETF
VIG
|
+$522K |
| 5 |
Vanguard Morningstar Small-Cap Value ETF
VBR
|
+$518K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$639K |
| 2 |
Chevron
CVX
|
+$538K |
| 3 |
GSK
GSK
|
+$425K |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$359K |
| 5 |
TSMC
TSM
|
+$339K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.6% |
| 2 | Consumer Staples | 12.2% |
| 3 | Technology | 10.83% |
| 4 | Financials | 9.85% |
| 5 | Healthcare | 7.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
CVS Health
CVS
$118B
| $864K | 0.34% |
11,915
-2,442
| -17% | -$178K |
2016 Q2
6 quarters
|
|
|
77
Vanguard Morningstar Small-Cap Value ETF
VBR
$36.1B
| $840K | 0.33% |
6,329
+3,982
| +170% | +$518K |
2017 Q3
1 quarter
|
|
78
GE Aerospace
GE
$324B
| $835K | 0.33% |
9,982
-1,115
| -10% | -$106K |
2016 Q2
6 quarters
|
|
79
Novartis
NVS
$286B
| $812K | 0.32% |
10,793
-701
| -6% | -$52.9K |
2016 Q2
6 quarters
|
|
80
Intel
INTC
$504B
| $810K | 0.32% |
17,550
+497
| +3% | +$21.7K |
2016 Q2
6 quarters
|
|
81
Pfizer
PFE
$168B
| $806K | 0.32% |
23,445
+2
| +0% | +$68 |
2016 Q2
6 quarters
|
|
82
DELISTED
Diamond Offshore Drilling
DO
| $787K | 0.31% |
42,315
-2,860
| -6% | -$46.5K |
2016 Q2
6 quarters
|
|
83
Schwab US Broad Market ETF
SCHB
$44.9B
| $778K | 0.31% |
72,342
+16,854
| +30% | +$177K |
2016 Q2
6 quarters
|
|
84
iShares Core S&P 500 ETF
IVV
$889B
| $775K | 0.3% |
2,882
-108
| -4% | -$28.3K |
2016 Q2
6 quarters
|
|
85
Merck
MRK
$358B
| $760K | 0.3% |
14,156
-1,040
| -7% | -$57.7K |
2016 Q2
6 quarters
|
|
86
Meta Platforms (Facebook)
META
$1.88T
| $758K | 0.3% |
4,297
+220
| +5% | +$38.9K |
2016 Q2
6 quarters
|
|
|
87
GSK
GSK
$98.2B
| $751K | 0.29% |
16,939
-9,199
| -35% | -$425K |
2016 Q2
6 quarters
|
|
|
RDS.A
88
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $751K | 0.29% |
11,264
-496
| -4% | -$31.3K |
2016 Q2
6 quarters
|
|
89
JPMorgan Chase
JPM
$891B
| $739K | 0.29% |
6,912
+23
| +0.3% | +$2.33K |
2016 Q2
6 quarters
|
|
90
Globe Life
GL
$12.9B
| $719K | 0.28% |
7,921
-554
| -7% | -$47.5K |
2016 Q2
6 quarters
|
|
91
The Kraft Heinz Company
KHC
$27.6B
| $717K | 0.28% |
9,217
+154
| +2% | +$12.1K |
2016 Q2
6 quarters
|
|
92
Texas Pacific Land
TPL
$23.9B
| $706K | 0.28% |
14,220
| – | – |
2016 Q2
6 quarters
|
|
93
Lockheed Martin
LMT
$123B
| $698K | 0.27% |
2,174
+50
| +2% | +$15.8K |
2016 Q2
6 quarters
|
|
94
Qualcomm
QCOM
$191B
| $679K | 0.27% |
10,599
-115
| -1% | -$6.97K |
2016 Q2
6 quarters
|
|
95
Alphabet (Google) Class C
GOOG
$4.22T
| $631K | 0.25% |
12,060
-3,120
| -21% | -$159K |
2016 Q2
6 quarters
|
|
96
Mastercard
MA
$540B
| $625K | 0.25% |
4,127
+101
| +3% | +$15K |
2016 Q2
6 quarters
|
|
97
Franklin Templeton
BEN
$15.9B
| $607K | 0.24% |
14,015
+240
| +2% | +$10.4K |
2016 Q2
6 quarters
|
|
98
Stryker
SYK
$112B
| $591K | 0.23% |
3,820
+2
| +0.1% | +$305 |
2016 Q2
6 quarters
|
|
99
General Dynamics
GD
$91.2B
| $571K | 0.22% |
2,805
-237
| -8% | -$48.4K |
2016 Q3
5 quarters
|
|
100
Vanguard Morningstar Growth ETF
VUG
$232B
| $562K | 0.22% |
23,988
| – | – |
2016 Q2
6 quarters
|
|
Similar funds
PTC
Nicholas Hoffman & Company's Q4 2017 Portfolio in Review
As of Q4 2017, Nicholas Hoffman & Company held 173 positions worth $255M, up 7.3% from $237M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Nicholas Hoffman & Company's Q4 2017 filing shows 9 new, 70 increased, 65 reduced and 7 closed positions. Its largest new stake was State Street SPDR S&P Pharmaceuticals ETF: 10,289 shares worth $448K. The largest sale was Walmart Inc, an estimated $639K.
By sector, the portfolio is most concentrated in Miscellaneous at 40% of assets, up from 38% a quarter earlier, followed by Consumer Staples and Technology.
- Nicholas Hoffman & Company's largest Q4 2017 buy was State Street SPDR S&P Pharmaceuticals ETF: 10,289 shares worth $448K.
- Nicholas Hoffman & Company added most to Vanguard S&P 500 ETF in Q4 2017, an estimated $2.37M increase.
- Nicholas Hoffman & Company's biggest Q4 2017 reduction was Walmart Inc, cutting an estimated $639K.
- Nicholas Hoffman & Company fully exited Celgene Corp in Q4 2017, selling an estimated $260K.
- Nicholas Hoffman & Company's ten largest holdings make up 41% of its $255M portfolio in Q4 2017.
- Nicholas Hoffman & Company opened 9 new positions and closed 7 in Q4 2017.
- Nicholas Hoffman & Company's portfolio value rose 7.3% quarter-over-quarter to $255M.
Based on Nicholas Hoffman & Company's 13F filing for Q4 2017, filed 9 Feb 2018.